Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$110,756,219
+$9,666,880 QoQ
Shares Held
452,491
-24.3% QoQ
Ownership
0.864%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 503 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Dec 31, 2024CallValue
$12,353,060
CallShares
146,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AXSM ranks #21 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AXSM
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,756,219 | 452,491 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $101,089,339 | 598,091 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $112,877,543 | 618,033 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,875,145 | 361,261 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $78,650,452 | 753,429 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $62,268,987 | 533,902 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,310,102 | 204,587 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $12,353,060 | 146,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $179,740 | 2,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $65,382,939 | 727,528 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $161,000 | 2,000 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $71,724,291 | 890,985 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,819,896 | 185,713 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $119,700 | 1,500 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $14,021,128 | 176,167 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,594,733 | 37,126 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,085,374 | 29,020 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,006,879 | 32,537 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,408,459 | 31,226 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,706,668 | 38,249 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,091,789 | 54,616 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,875,792 | 45,320 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,391,207 | 36,824 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,325,451 | 40,214 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,961,802 | 29,081 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,713,544 | 30,264 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,036,828 | 25,001 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $782,110 | 10,977 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,429,037 | 17,368 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,121,416 | 19,062 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||